Immunosensitization of Tumor Cells to Dendritic Cell-Activated Immune Responses with the Proteasome Inhibitor Bortezomib (PS-341, Velcade)1
暂无分享,去创建一个
B. Comin-Anduix | A. Ribas | W. McBride | D. Vo | B. Bonavida | J. Economou | J. Glaspy | V. Dissette | H. Garbán | Sharla K. Owens | Lana Schumacher